Dato' Iskandar Mizal bin Mahmood

Name
Dato' Iskandar Mizal bin Mahmood
Nationality
Malaysian
Gender
Male
Age
48
Salutation
DATO'
Designation
Chief Executive Officer
Qualification
Bachelor of Science in Business Administration (Accounting) from Boston University, Massachusetts, United States of America.
Working Experience
Dato’ Iskandar was the founding Chief Executive Officer ("CEO") and a Board member of Malaysian Biotechnology Corporation Sdn Bhd (BiotechCorp), which is the Malaysian Government’s professional agency spearheading the development of the country’s biotechnology industry. He was also the Chairman of the Board of Malaysian Bio-XCell Sdn Bhd, a 60% subsidiary of BiotechCorp that is undertaking the development of a comprehensive biotechnology ecosystem located in Iskandar Malaysia, Johor with UEM Sunrise Berhad. Under Dato’ Iskandar’s leadership, BiotechCorp has grown to be one of the leading biotechnology industry developmental organisations within the region. Prior to his appointment to BiotechCorp, Dato’ Iskandar was the CEO and a Board member of Malaysian Technology Development Corporation Sdn Bhd, Malaysia’s integrated venture capital company. Before that, he was with Malaysia Airports Holdings Berhad holding several senior management positions and portfolios. He has also served with several investment banking institutions including CIMB Group and Bumiputra Merchant Bankers. Dato’ Iskandar was the Managing Director and CEO of Manipal Education Malaysia Sdn Bhd ("MEM") for approximately two years before his appointment as Group CEO of the Company. Under his stewardship, MEM obtained a full university licence to operate Manipal International University. On 1 July 2013, Dato' Iskandar was appointed Group Director at DRB-HICOM Berhad.
Directorship of Public Companies
Globetronics Technology Berhad
Direct (units)
0
Direct (%)
0.00%
Indirect (units)
0
Indirect (%)
0.00%
Total (units)
0
Total (%)
0.00%
Date of Notice

Changes
Ann. Date Date Type Name Title View
Related Stocks
Market Buzz
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment